BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 15755877)

  • 1. A nonclassic CCAAT enhancer element binding protein binding site contributes to alpha-methylacyl-CoA racemase expression in prostate cancer.
    Zha S; Isaacs WB
    Mol Cancer Res; 2005 Feb; 3(2):110-8. PubMed ID: 15755877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.
    Luo J; Zha S; Gage WR; Dunn TA; Hicks JL; Bennett CJ; Ewing CM; Platz EA; Ferdinandusse S; Wanders RJ; Trent JM; Isaacs WB; De Marzo AM
    Cancer Res; 2002 Apr; 62(8):2220-6. PubMed ID: 11956072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
    Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
    Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer.
    Zha S; Ferdinandusse S; Denis S; Wanders RJ; Ewing CM; Luo J; De Marzo AM; Isaacs WB
    Cancer Res; 2003 Nov; 63(21):7365-76. PubMed ID: 14612535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branched fatty acids in dairy and beef products markedly enhance alpha-methylacyl-CoA racemase expression in prostate cancer cells in vitro.
    Mobley JA; Leav I; Zielie P; Wotkowitz C; Evans J; Lam YW; L'Esperance BS; Jiang Z; Ho SM
    Cancer Epidemiol Biomarkers Prev; 2003 Aug; 12(8):775-83. PubMed ID: 12917210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 inhibits human peroxisome proliferator activated receptor alpha gene expression via CCAAT/enhancer-binding proteins in hepatocytes.
    Chew CH; Chew GS; Najimudin N; Tengku-Muhammad TS
    Int J Biochem Cell Biol; 2007; 39(10):1975-86. PubMed ID: 17616429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway.
    Swinnen JV; Heemers H; Deboel L; Foufelle F; Heyns W; Verhoeven G
    Oncogene; 2000 Oct; 19(45):5173-81. PubMed ID: 11064454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
    Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
    Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A variant of the alpha-methyl-acyl-CoA racemase gene created by a deletion in exon 5 and its expression in prostate cancer.
    Mubiru JN; Valente AJ; Troyer DA
    Prostate; 2005 Oct; 65(2):117-23. PubMed ID: 15880524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk.
    Zheng SL; Chang BL; Faith DA; Johnson JR; Isaacs SD; Hawkins GA; Turner A; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
    Cancer Res; 2002 Nov; 62(22):6485-8. PubMed ID: 12438241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the promoter region required for human adiponectin gene transcription: Association with CCAAT/enhancer binding protein-beta and tumor necrosis factor-alpha.
    Kita A; Yamasaki H; Kuwahara H; Moriuchi A; Fukushima K; Kobayashi M; Fukushima T; Takahashi R; Abiru N; Uotani S; Kawasaki E; Eguchi K
    Biochem Biophys Res Commun; 2005 Jun; 331(2):484-90. PubMed ID: 15850785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
    Polzin RG; Benlhabib H; Trepel J; Herrera JE
    Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1.
    Anli J; Pengju Z; Xiaoyan H; Wenwei C; Zhifang L; Feng K; Huiqing Y; Jianye Z
    Prostate; 2006 Sep; 66(12):1339-46. PubMed ID: 16845664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative spliced variants of the alpha-methylacyl-CoA racemase gene and their expression in prostate cancer.
    Mubiru JN; Shen-Ong GL; Valente AJ; Troyer DA
    Gene; 2004 Feb; 327(1):89-98. PubMed ID: 14960364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heregulin and forskolin-induced cyclin D3 expression in Schwann cells: role of a CCAAT promoter element and CCAAT enhancer binding protein.
    Fuentealba L; Schworer C; Schroering A; Rahmatullah M; Carey DJ
    Glia; 2004 Feb; 45(3):238-48. PubMed ID: 14730697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
    Klick DE; Shadley JD; Hines RN
    Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisomal branched chain fatty acid beta-oxidation pathway is upregulated in prostate cancer.
    Zha S; Ferdinandusse S; Hicks JL; Denis S; Dunn TA; Wanders RJ; Luo J; De Marzo AM; Isaacs WB
    Prostate; 2005 Jun; 63(4):316-23. PubMed ID: 15599942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 stimulates S100A8 expression by activating protein kinase A and CCAAT/enhancer-binding-protein-beta in prostate cancer cells.
    Miao L; Grebhardt S; Shi J; Peipe I; Zhang J; Mayer D
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1919-28. PubMed ID: 22728165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and regulation of the meprin beta gene in human cancer cells.
    Matters GL; Bond JS
    Mol Carcinog; 1999 Jul; 25(3):169-78. PubMed ID: 10411143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic fluorescence reverse transcriptase-polymerase chain reaction for alpha-methylacyl CoA racemase distinguishes prostate cancer from benign lesions.
    Schostak M; Miller K; Krause H; Schrader M; Kempkensteffen C; Kollermann J
    Cancer Detect Prev; 2006; 30(5):449-54. PubMed ID: 17067752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.